Skip to main content
. 2011 May 31;52(6):3825–3831. doi: 10.1167/iovs.10-6797

Figure 4.

Figure 4.

ELISA analysis of TNF-α (A) and MCP-1 (B) activity three days after RD creation. While the level of MCP-1 and TNF-α was increased after RD, treatment with edaravone significantly reduced MCP-1 and TNF-α expression. Data are expressed as the mean ± SE, n = 4–6. *P < 0.05, **P < 0.01.